Chemours Co (CC)

Currency in USD
15.26
-0.35(-2.24%)
Closed·
15.260.00(0.00%)
·
Earnings results expected in 15 days
CC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.7615.35
52 wk Range
9.1320.07
Key Statistics
Prev. Close
15.61
Open
15
Day's Range
14.76-15.35
52 wk Range
9.13-20.07
Volume
2.77M
Average Volume (3m)
2.69M
1-Year Change
-23.3551%
Book Value / Share
1.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.00
Upside
+4.85%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Chemours Co News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Chemours Co Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. The company sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Industry
Chemicals
Employees
6000

Chemours Co SWOT Analysis


Strategic Resilience
Chemours demonstrates adaptability amidst industry challenges, implementing cost-saving measures and diversifying its product portfolio to maintain competitive edge
Regulatory Catalysts
Explore how environmental regulations are driving demand for Chemours' eco-friendly refrigerants and cooling solutions, particularly in the TSS segment
Financial Outlook
Analysts project EBITDA of $825-975 million for FY 2025, with price targets ranging from $19 to $27, reflecting cautious optimism about growth potential
Innovation Frontie
Delve into Chemours' data center cooling technology, which could capture a substantial share of a $3 billion market and significantly boost future earnings
Read full SWOT analysis

Chemours Co Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $0.13 missed forecast of $0.23; revenue slightly exceeded at $1.37 billion
  • Stock dropped 9.09% in premarket trading; adjusted EBITDA fell to $166 million from $191 million YoY
  • Company reduced dividend by 65% to enhance balance sheet flexibility
  • FY2025 adjusted EBITDA guidance set at $825-950 million; free cash flow conversion of 60-80% expected in H2
  • Strategic focus on next-gen refrigerants and liquid cooling market highlighted by executives
Last Updated: 2025-05-07, 09:20 a/m
Read Full Transcript

Compare CC to Peers and Sector

Metrics to compare
CC
Peers
Sector
Relationship
P/E Ratio
−7.1x17.2x1.7x
PEG Ratio
0.01−0.090.00
Price/Book
7.7x0.8x1.6x
Price / LTM Sales
0.4x0.4x1.4x
Upside (Analyst Target)
−3.9%5.2%15.7%
Fair Value Upside
Unlock21.1%−2.4%Unlock

Analyst Ratings

5 Buy
4 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 16.00
(+4.85% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Buy18.00+17.96%16.00MaintainJan 16, 2026
BMO Capital
Buy20.00+31.06%18.00MaintainJan 16, 2026
RBC Capital
Buy16.00+4.85%17.00MaintainDec 16, 2025
JPMorgan
Hold13.00-14.81%15.00MaintainDec 03, 2025
Jefferies
Hold14.00-8.26%16.00MaintainNov 10, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -2.13%
Dividend Yield
2.29%
Industry Median 2.58%
Annualized payout
0.35
Paid quarterly
5-Years Growth
-7.56%
Growth Streak

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
0.20 / 0.27
Revenue / Forecast
1.50B / 1.50B
EPS Revisions
Last 90 days

CC Income Statement

People Also Watch

211.71
MTB
-0.27%
22.55
OLN
-3.67%
27.63
RF
-0.50%
59.09
ZION
-0.89%
70.56
AOS
-2.65%

FAQ

What Is the Chemours Co (CC) Stock Price Today?

The Chemours Co stock price today is 15.26

What Stock Exchange Does Chemours Co Trade On?

Chemours Co is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Chemours Co?

The stock symbol for Chemours Co is "CC."

Does Chemours Co Pay Dividends? What’s The Current Dividend Yield?

The Chemours Co dividend yield is 2.29%.

What Is the Chemours Co Market Cap?

As of today, Chemours Co market cap is 2.29B.

What Is Chemours Co's Earnings Per Share (TTM)?

The Chemours Co EPS (TTM) is -2.13.

When Is the Next Chemours Co Earnings Date?

Chemours Co will release its next earnings report on Feb 05, 2026.

From a Technical Analysis Perspective, Is CC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Chemours Co Stock Split?

Chemours Co has split 0 times.

How Many Employees Does Chemours Co Have?

Chemours Co has 6000 employees.

What is the current trading status of Chemours Co (CC)?

As of Jan 21, 2026, Chemours Co (CC) is trading at a price of 15.26, with a previous close of 15.61. The stock has fluctuated within a day range of 14.76 to 15.35, while its 52-week range spans from 9.13 to 20.07.

What Is Chemours Co (CC) Price Target According to Analysts?

The average 12-month price target for Chemours Co is USD16.00, with a high estimate of USD20 and a low estimate of USD13. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +4.85% Upside potential.

What Is the CC Premarket Price?

CC's last pre-market stock price is 14.87. The pre-market share volume is 24,890.00, and the stock has decreased by -0.74, or -4.74%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.